Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 14,103 | 14,499 | 13,009 | 13,048 | 11,068 |
| Operating Income | -14,103 | -14,499 | -13,009 | -13,048 | -11,068 |
| Other Income | -109 | 37 | 47 | 54 | 127 |
| Pre-tax Income | -14,212 | -14,462 | -12,962 | -12,994 | -10,941 |
| Net Income Continuous | -14,212 | -14,462 | -12,962 | -12,994 | -10,941 |
| Net Income | $-14,212 | $-14,462 | $-12,962 | $-12,994 | $-10,941 |
| EPS Basic Total Ops | -2.60 | -2.80 | -2.50 | -2.50 | -2.00 |
| EPS Basic Continuous Ops | -2.53 | -2.78 | -2.50 | -2.54 | -1.97 |
| EPS Diluted Total Ops | -2.60 | -2.80 | -2.50 | -2.50 | -2.00 |
| EPS Diluted Continuous Ops | -2.53 | -2.78 | -2.50 | -2.54 | -1.97 |
| EBITDA(a) | $-13,308 | $-13,713 | $-12,105 | $-12,162 | $-10,292 |